Detection of urinary podocytes by flow cytometry in idiopathic membranous nephropathy

被引:10
|
作者
Mella, Alberto [1 ]
Deambrosis, Ilaria [2 ]
Mingozzi, Silvia [1 ]
Colla, Loredana [1 ]
Burdese, Manuel [1 ]
Giaretta, Fulvia [2 ]
Bruno, Stefania [2 ,3 ]
Camussi, Giovanni [3 ]
Boaglio, Elena [1 ]
Dolla, Caterina [1 ]
Clari, Roberta [1 ]
Biancone, Luigi [1 ]
机构
[1] Univ Turin, Div Nephrol Dialysis & Transplantat, Dept Med Sci, Citta Salute & Sci Hosp, I-8810126 Corso, Italy
[2] Citta Salute & Sci Hosp, Lab Nephrol & Immunopathol, Turin, Italy
[3] Univ Turin, Dept Med Sci, Turin, Italy
关键词
DISEASE-ACTIVITY; RECEPTOR; AUTOANTIBODIES; PROGRESSION; CELLS;
D O I
10.1038/s41598-020-73335-2
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Idiopathic membranous nephropathy (iMN) is considered an immune-mediated disease where circulating autoantibodies against podocyte targets (mainly the PLA(2)R) cause the deposition of in-situ subepithelial immune-complexes. The consequent podocyte damage may cause cell detachment in urine (Podocyturia-PdoU). PdoU has been assessed in different kidney diseases, but limited data are available in iMN. In this study all patients with a diagnosis of iMN between 15/12/1999-16/07/2014 were tested for PLA(2)R antibodies (Ab anti-PLA(2)R, ELISA kit) and PdoU by flow cytometry with anti-podocalyxin antibody. A semi-quantitative PdoU score was defined according to the percentage of podocalyxin positive cells normalized to the total volume of sample and set relative to the urine creatinine measured in the supernatant. PdoU was positive in 17/27 patients (63%; 1+score in 6/27-22.2%, 2+in 4/27-14.8%, 3+in 2/27-7.4%, 4+in 5/27-18.5%). Only 2/7 patients with complete remission showed a positive PdoU (1+) while all six patients without remission have significant PdoU. PdoU+was statistically correlated with the absence of remission and Ab anti-PLA(2)R+(p<0.05) but PdoU, analysed as a continuous variable, showed a non-linear correlation with proteinuria or PLA(2)R antibody levels also in the cohort of patients with two available PdoU tests. In conclusion, PdoU could be detected in iMN and seems to be associated with commonly considered markers of disease activity (proteinuria and Ab anti-PLA(2)R) with a non-linear correlation. Despite data should be confirmed in large and prospective cohorts, according to the podocyte depletion hypothesis PdoU may represent an early marker of immunological activation with potential prognostic utility.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Serum Anti-PLA2R Antibody Predicts Treatment Outcome in Idiopathic Membranous Nephropathy
    Wei, Shi-Yao
    Wang, Yu-Xiao
    Li, Jian-Si
    Zhao, Shi-Lei
    Diao, Tian-Tian
    Wang, Yu
    Wang, Chang
    Qin, Ying
    Cao, Yang
    Wei, Qiuju
    Li, Bing
    AMERICAN JOURNAL OF NEPHROLOGY, 2016, 43 (02) : 129 - 140
  • [42] Clinical Predictors of Response to Prednisone Plus Cyclophosphamide in Patients with Idiopathic Membranous Nephropathy
    Li, Shu
    Wang, Ling
    Zhang, Minfang
    Zhou, Wenyan
    Fang, Wei
    Wang, Qin
    Qi, Chaojun
    Mou, Shan
    Shao, Xinghua
    Ni, Zhaohui
    NEPHRON, 2017, 135 (02) : 87 - 96
  • [43] First Identification of an Antigen in Autoimmune Idiopathic Membranous Nephropathy: Toward Targeted Therapy?
    Ronco, Pierre
    Debiec, Hanna
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 55 (05) : 820 - 823
  • [44] Renal Phospholipase A2 Receptor and the Clinical Features of Idiopathic Membranous Nephropathy
    Xu, Ning-Xin
    Xie, Qiong-Hong
    Sun, Zhu-Xing
    Wang, Jia
    Li, Yan
    Wang, Liang
    Liu, Shao-Jun
    Xue, Jun
    Hao, Chuan-Ming
    CHINESE MEDICAL JOURNAL, 2017, 130 (08) : 892 - 898
  • [45] Antiphospholipase A2 Receptor Antibody Titer and Subclass in Idiopathic Membranous Nephropathy
    Hofstra, Julia M.
    Debiec, Hanna
    Short, Colin D.
    Pelle, Tinnothee
    Kleta, Robert
    Mathieson, Peter W.
    Ronco, Pierre
    Brenchley, Paul E.
    Wetzels, Jack F.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (10): : 1735 - 1743
  • [46] Treatment of rituximab in patients with idiopathic membranous nephropathy: a case series and literature review
    Jeon, Soo-Jee
    Kim, Ji-Hye
    Noh, Hee-Won
    Lee, Ga-Young
    Lim, Jeong-Hoon
    Jung, Hee-Yeon
    Cho, Jang-Hee
    Choi, Ji-Young
    Kim, Chan-Duck
    Kim, Yong-Lim
    Park, Sun-Hee
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2022, 37 (04): : 830 - 840
  • [47] TRPC6 Single Nucleotide Polymorphisms and Progression of Idiopathic Membranous Nephropathy
    Hofstra, Julia M.
    Coenen, Marieke J. H.
    Schijvenaars, Mascha M. V. A. P.
    Berden, Jo H. M.
    van der Vlag, Johan
    Hoefsloot, Lies H.
    Knoers, Nine V. A. M.
    Wetzels, Jack F. M.
    Nijenhuis, Tom
    PLOS ONE, 2014, 9 (07):
  • [48] The role of adiponectin and its receptor in patients with idiopathic membranous nephropathy complicated with hyperuricemia
    Liu, Tong
    Xia, Mengdi
    Zhang, Yongji
    Wang, Yibin
    Zhou, Yun
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2021, 149 (5-6) : 288 - 294
  • [49] Idiopathic Membranous Nephropathy: Glomerular Pathological Pattern Caused by Extrarenal Immunity Activity
    Liu, Wenbin
    Gao, Chang
    Liu, Zhiyuan
    Dai, Haoran
    Feng, Zhendong
    Dong, Zhaocheng
    Zheng, Yang
    Gao, Yu
    Tian, Xuefei
    Liu, Baoli
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [50] Detection and prognostic relevance of PLA2R epitopes in idiopathic membranous nephropathy: a simultaneous quantitative multiplex suspension array detection method
    Wu, Juan
    Zhang, Qingjuan
    Du, Yuanyuan
    Zheng, Tianyu
    Jin, Juan
    Kao, Shangbin
    Zhou, Xiumei
    Qin, Yuan
    Zhao, Xueqin
    He, Qiang
    Yang, Fuzhou
    Huang, Biao
    CLINICAL KIDNEY JOURNAL, 2025, 18 (03)